These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 7583862)

  • 1. Efficacy of once daily extended-release theophylline in decreasing the use of inhaled beta 2-agonists in stable, mild-to-moderate asthma patients.
    Edwards TB; Dockhorn RJ; Wagner DE; Fiddes RA; Grossman J; Menendez R; Southern DL; Cefali EA; Hassanein RS
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):409-16. PubMed ID: 7583862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in health care resource utilization associated with extended-release theophylline.
    Schulz RM; Yates WN
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):267-72. PubMed ID: 10094217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G; Williams DA; Weller P; Price JF
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the efficacy and safety of q. d. theophylline therapy: a multicenter study.
    Dockhorn RJ; Green AW; Green E
    Ann Allergy; 1985 Nov; 55(5):658-64. PubMed ID: 2865917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
    Goldstein MF; Chervinsky P
    Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline.
    Inoue H; Komori M; Matsumoto T; Fukuyama S; Matsumura M; Nakano T; Tsuda M; Matsumoto K; Kanaya A; Moriwaki A; Aizawa H; Yoshida M; Nakanishi Y
    Respiration; 2007; 74(6):611-6. PubMed ID: 16960440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of slow-release theophylline on airway inflammation in bronchial asthma].
    Adachi M; Minoguchi K; Mita S; Kokubu F; Suzuki H; Sano Y; Akiyama K; Yasuhara H
    Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
    Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sustained-release theophylline in nocturnal asthma.
    Freeman W; Packe GE; Cayton RM
    Br J Clin Pract; 1991; 45(1):21-5. PubMed ID: 1931534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline in maintenance treatment of chronic asthma: concentration-dependent additional effect to beta 2-agonist therapy.
    Billing B; Dahlqvist R; Hörnblad Y; Leideman T; Skareke L; Ripe E
    Eur J Respir Dis; 1987 Jan; 70(1):35-43. PubMed ID: 2880747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhaled beta agonists as a bronchodilator are a mainstay of asthma therapy: focusing on inhaled beta agonists and oral theophylline].
    Nishimura K; Izumi T
    Nihon Rinsho; 1996 Nov; 54(11):3073-7. PubMed ID: 8950957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-a-day dosing with theophylline: a comparison of four sustained-release products.
    Minotti DA; Altman LC; Ayars GH; Popick FR; Benn VJ
    Ann Allergy; 1992 Jun; 68(6):500-6. PubMed ID: 1610026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal asthma therapy. Inhaled bitolterol versus sustained-release theophylline.
    Zwillich CW; Neagley SR; Cicutto L; White DP; Martin RJ
    Am Rev Respir Dis; 1989 Feb; 139(2):470-4. PubMed ID: 2643904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.
    Yurdakul AS; Taci N; Eren A; Sipit T
    Respir Med; 2003 Dec; 97(12):1313-9. PubMed ID: 14682413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined theophylline/beta-agonists maintenance therapy in chronic asthma.
    Eriksson NE; Haglind K; Ewald U
    Eur J Respir Dis; 1983 Apr; 64(3):172-7. PubMed ID: 6132832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nedocromil sodium therapy in asthma patients. Therapeutic effect in addition to treatment with oral theophylline and inhaled bronchodilator agents].
    Boos R; van Kampen C; Weede W; Beck W
    Fortschr Med; 1989 Nov; 107(33):712-6. PubMed ID: 2557274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.